M53-25663-91411
4 vaccinations
1 coded response
30 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 100 / NY
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Pfizer-BioNTech
-
2021-03-19
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-24
- 2021-03-26
- 2021-04-02
-
2021-04-09
Dose 2 — Pfizer-BioNTech
- 2021-04-09
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-16
- 2021-04-25
- 2021-04-30
- 2021-05-07
- 2021-05-16
- 2021-05-21
- 2021-07-09
- 2021-10-09
-
2021-12-01
Dose 3 — Pfizer-BioNTech
- 2022-04-11
-
2022-09-29
Dose 4 — Pfizer-BioNTech
-
2022-09-30
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-10-01
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-10-03
- 2022-10-05
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-10-29
- 2022-11-03
- 2022-11-12
-
2023-03-30
Survey response — 6 months, dose 4MedDRA: Brain fog, COVID-19, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-30
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-03-31
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-09 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
| 4 | 2022-09-29 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release